Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Abroad (travel likely)RecruitingPHASE3
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Atypical Hemolytic Uremic Syndrome
Locations
- Novartis Investigative Site, Nanjing, Jiangsu, China
- Novartis Investigative Site, Beijing, China
- Novartis Investigative Site, Beijing, China
- Novartis Investigative Site, Shanghai, China
- Novartis Investigative Site, Bordeaux, France
- Novartis Investigative Site, Paris, France
- Novartis Investigative Site, Paris, France
- Novartis Investigative Site, Rouen, France
- Novartis Investigative Site, Toulouse, France
- Novartis Investigative Site, Tours, France
- Novartis Investigative Site, Essen, Germany
- Novartis Investigative Site, Kiel, Germany
- Novartis Investigative Site, Ranica, BG, Italy
- Novartis Investigative Site, Milan, MI, Italy
- Novartis Investigative Site, Roma, RM, Italy
- Novartis Investigative Site, Matsumoto-shi, Nagano, Japan
- Novartis Investigative Site, Iruma-gun, Saitama, Japan
- Novartis Investigative Site, Bunkyo Ku, Tokyo, Japan
- Novartis Investigative Site, Santiago Compostela, A Coruna, Spain
- Novartis Investigative Site, Barcelona, Spain
- Novartis Investigative Site, Córdoba, Spain
- Novartis Investigative Site, Málaga, Spain
- Novartis Investigative Site, Seville, Spain
- Novartis Investigative Site, Valencia, Spain
- Novartis Investigative Site, Izmir, Balcova, Turkey (Türkiye)
- Novartis Investigative Site, Köseköy, Kocaeli, Turkey (Türkiye)
- Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)
- Novartis Investigative Site, Mersin, Yenisehir, Turkey (Türkiye)
- Novartis Investigative Site, Glasgow, Scotland, United Kingdom
- Novartis Investigative Site, Newcastle upon Tyne, Tyne and Wear, United Kingdom
- Novartis Investigative Site, London, United Kingdom